Trial reportMedicine2026
Short-term efficacy of intense pulsed light in the treatment of hordeolum: A prospective cohort study.
Trial report in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The study aims to evaluate the efficacy of conservative treatment of hordeolum with intense pulsed light (IPL), compared with the medication treatment of hordeolum. Eighty patients with hordeolum who received treatment at the ophthalmology clinic of Quzhou People's Hospital from June 2023 to December 2024 were selected. Patients were randomly assigned to the control group and the experimental group using the principle of random allocation. The control group received external drug application combined with local hot compress treatment, while the experimental group received 1 session of IPL treatment for the ocular skin, followed by local hot compress treatment. Ocular surface disease index (OSDI) scores and noninvasive tear meniscus height information were collected from all patients with ocular discomfort symptoms before and after treatment. Furthermore, anterior segment photographs and images depicting meibomian gland morphology were obtained from patients both prior to and following treatment. The duration of recovery and surgical rates for the 2 groups were documented. A comparative analysis was conducted to evaluate the efficacy before and after treatment and to assess the differences between the 2 groups posttreatment. The results indicated no statistically significant difference in OSDI scores within the medication group before and after treatment (P > .05). Conversely, the IPL group exhibited a statistically significant reduction in OSDI scores following treatment (P < .05). Posttreatment, the medication group demonstrated higher OSDI scores, longer recovery times (in days) and increased surgical rates compared to the IPL group with these differences reaching statistical significance (P < .05). Intense pulsed light is a more efficient and convenient method for treating hordeolum, compared with the medication treatment of hordeolum.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.